Resmed (RMD) Non-Current Assets (2010 - 2026)

Resmed has reported Non-Current Assets for 17 years, with the latest figure at $4.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets rose 8.3% year-over-year to $4.7 billion; the trailing twelve-month figure through Mar 2026 stood at $4.7 billion (up 8.3% YoY), and the FY2025 full-year result was $4.7 billion, up 3.41% from the prior year.
• Non-Current Assets for Q1 2026 stood at $4.7 billion, up from $4.7 billion in the prior quarter.
• The five-year high for Non-Current Assets was $4.7 billion in Q1 2026, with the low at $3.1 billion in Q3 2022.
• Historically, Non-Current Assets has averaged $4.3 billion across 5 years, with a median of $4.4 billion in 2023.
• Annual changes were most pronounced in 2023 — Non-Current Assets surged 41.11% — and 2024, when it retreated 4.9%.
• Resmed's Non-Current Assets stood at $4.4 billion in 2022, then advanced by 4.05% to $4.5 billion in 2023, then decreased by 4.9% to $4.3 billion in 2024, then advanced by 8.81% to $4.7 billion in 2025, then increased by 0.76% to $4.7 billion in 2026.
• The last three Non-Current Assets figures came in at $4.7 billion (Q1 2026), $4.7 billion (Q4 2025), and $4.7 billion (Q3 2025), per Business Quant data.